Atrial Fibrillation

Patients who receive hemodialysis prior to their first kidney transplant may be more likely to develop atrial fibrillation compared with patients who have peritoneal dialysis, according to recent data.

With nearly 90% accuracy, an artificial intelligence-based model consistently predicted atrial fibrillation within 31 days among patients with sinus rhythm, according to findings published in JAMA Cardiology.

InfoBionic announced it received FDA 510(k) clearance for its next-generation remote ECG monitoring device with a Bluetooth diagnostic six-lead sensor for patients who require cardiac monitoring.

People who have difficulty sleeping or sleep less than 6 hours per day have a higher likelihood of developing hypertension, according to a study analyzing data from more than 66,000 participants.

For millions of patients who live with atrial fibrillation, early detection and treatment are essential because research shows that early, intensive management of AF reduces stroke, hospitalization and heart failure.

Patients hospitalized for a noncardiac reason with a first-time atrial fibrillation event in-hospital were more likely to have a recurrent event in the 12 months after discharge vs. matched controls with no prior AF, researchers reported.

Boston Scientific announced the FDA clearance and launch of its next-generation insertable cardiac monitor for long-term monitoring of arrhythmias associated with atrial fibrillation, cryptogenic stroke and syncope.

Healio and Cardiology Today have compiled a list of the top news in cardiology of September 2023.

Vitamin D deficiency was associated with a marginally increased risk for atrial fibrillation, and increases in serum vitamin D were linked to a decreased risk, according to the results of a meta-analysis.

Data suggest that left atrial scarring observed with 2D long-axis MRI is associated with adverse atrial remodeling and incident clinically detected atrial fibrillation, researchers reported.